Advanced Wound Care EU 2022

Advanced Wound Care Summit

The first industry-led forum focused on delivering innovative wound care treatments to patients

DOWNLOAD THE AGENDA
Berlin, Germany
13-14 December, 2022

“This was a very well curated industry forum, with focus on payer and providers. It brought key industry players together. It was a very productive 2 days for me as an executive. ”

Ankit Agarwal, CEO and Founder of Imbed Biosciences

Welcome to The Advanced Wound Care Summit

The Advanced Wound Care Summit EU is the first industry-led, EU-focused, forum on commercialising innovative wound care products. How will you comply with the EU MDR? What is the best strategy to ensure widespread clinical adoption and reimbursement? What can you do to engage with other wound care companies, for collaboration or acquisition? Expect to hear from, and network with, wound care leaders, across large wound care companies and SMEs.

Find out how C-level Executives, VPs and Directors of R&D are tackling the most pressing industry challenges, seizing growth opportunities, and building innovation. Whether an executive, investor, researcher or healthcare professional, this meeting offers an empowering environment that allows you to secure your stake in the AWC market

2
Main Event Days
20+
Industry Leading Speakers
100+
Industry Experts
15+
Dedicated Networking Hours

Step into interactive discussions and engaging presentations on the key challenges and opportunities presented by wound care today:

  1. Ensure your company complies with EU regulation to avoid costly litigation by hearing from regulatory experts
  2. Outlining effective clinical trial design for novel wound care products, such as digital medical devices
  3. Securing reimbursement for your advanced wound care product by hearing from companies who have already done
  4. Network with multinational wound care companies to ensure investment in your innovative advanced wound care product
  5. Identify novel opportunities in the wound care sector by discussing what the future of the field will by from KOLs

WHO YOU WILL MEET

30%
Small wound care companies
35%
Multinational Wound Care Companies
15%
Healthcare Professionals & Academics
15%
Service & Technology Providers; CMOs/CDMOs
5%
Regulators

Small wound care companies

Multinational Wound Care Companies

Healthcare Professionals & Academics

Service & Technology Providers; CMOs/CDMOs

Regulators

OUR INDUSTRY LEADING SPEAKERS

 

David Goldsmith

Chief Medical Officer
SolasCure

David Goldsmith

Chief Medical Officer
SolasCure

David Goldsmith

Chief Medical Officer
SolasCure
 

Kent Nielsen

Principal Scientist, New Business Development
Coloplast

Kent Nielsen

Principal Scientist, New Business Development
Coloplast

Kent Nielsen

Principal Scientist, New Business Development
Coloplast
 

Helen Shaw

Director
Convatec

Helen Shaw

Director
Convatec

Helen Shaw

Director
Convatec
 

Isabel Henkel

Global Director Market Access
Essity

Isabel Henkel

Global Director Market Access
Essity

Isabel Henkel

Global Director Market Access
Essity
 

Helen Thomason

Medical Science Liaison Manager EMEA
3M

Helen Thomason

Medical Science Liaison Manager EMEA
3M

Helen Thomason

Medical Science Liaison Manager EMEA
3M
 

Rafael Mazuz

Managing Director
Diligence Wound Care Global

Rafael Mazuz

Managing Director
Diligence Wound Care Global

Rafael Mazuz

Managing Director
Diligence Wound Care Global
 

Karsten Hemmrich

Vice President, Health & Medical Solutions
Essity GmbH

Karsten Hemmrich

Vice President, Health & Medical Solutions
Essity GmbH

Karsten Hemmrich

Vice President, Health & Medical Solutions
Essity GmbH
 

David Nygren

VP of Advanced Wound Management Growth Opportunities
Smith & Nephew

David Nygren

VP of Advanced Wound Management Growth Opportunities
Smith & Nephew

David Nygren

VP of Advanced Wound Management Growth Opportunities
Smith & Nephew
 

Mike Griffiths

Chief Executive Officer & Medical Director
Advanced Oxygen Therapy

Mike Griffiths

Chief Executive Officer & Medical Director
Advanced Oxygen Therapy

Mike Griffiths

Chief Executive Officer & Medical Director
Advanced Oxygen Therapy
 

Robert Frykberg

Medical Director
DMPrevent

Robert Frykberg

Medical Director
DMPrevent

Robert Frykberg

Medical Director
DMPrevent
 

Andrew Cameron

Chief Executive Officer
Feeltect

Andrew Cameron

Chief Executive Officer
Feeltect

Andrew Cameron

Chief Executive Officer
Feeltect
 

Gadi Borkow

Chief Technology Officer and Co-Founder
MedCu Technologies

Gadi Borkow

Chief Technology Officer and Co-Founder
MedCu Technologies

Gadi Borkow

Chief Technology Officer and Co-Founder
MedCu Technologies
 

Jens Kirsch

Chief Executive Officer
Terraplasma Medical GMBH

Jens Kirsch

Chief Executive Officer
Terraplasma Medical GMBH

Jens Kirsch

Chief Executive Officer
Terraplasma Medical GMBH
 

Kyle Wu

Chief Medical Officer
Ekare

Kyle Wu

Chief Medical Officer
Ekare

Kyle Wu

Chief Medical Officer
Ekare
 

Fia Navntoft

Senior Clinical Project Manager
Molnlycke

Fia Navntoft

Senior Clinical Project Manager
Molnlycke

Fia Navntoft

Senior Clinical Project Manager
Molnlycke
 

Vincent Bouchiat

Chief Executive Officer and Co-Founder
Grapheal

Vincent Bouchiat

Chief Executive Officer and Co-Founder
Grapheal

Vincent Bouchiat

Chief Executive Officer and Co-Founder
Grapheal
 

Seema Suchdev

Senior Clinical Project Manager
Mölnlycke Healthcare

Seema Suchdev

Senior Clinical Project Manager
Mölnlycke Healthcare

Seema Suchdev

Senior Clinical Project Manager
Mölnlycke Healthcare
 

Monique Rennie

Vice President, Medical Affairs and Reimbursement
MolecuLight

Monique Rennie

Vice President, Medical Affairs and Reimbursement
MolecuLight

Monique Rennie

Vice President, Medical Affairs and Reimbursement
MolecuLight
 

Shahin Homaeigobar

Assistant Professor of Biomedical Engineering
University of Dundee

Shahin Homaeigobar

Assistant Professor of Biomedical Engineering
University of Dundee

Shahin Homaeigobar

Assistant Professor of Biomedical Engineering
University of Dundee
 

Barbara Wolff-Winiski

Co-chief Executive Officer and Chief Scientific Officer
Akribes

Barbara Wolff-Winiski

Co-chief Executive Officer and Chief Scientific Officer
Akribes

Barbara Wolff-Winiski

Co-chief Executive Officer and Chief Scientific Officer
Akribes
 

Laurent Decory

Chief Operating Officer
Aurealis Therapeutics

Laurent Decory

Chief Operating Officer
Aurealis Therapeutics

Laurent Decory

Chief Operating Officer
Aurealis Therapeutics
 

David Fairlamb

Head of Regulatory Affairs
SolasCure

David Fairlamb is currently Director of Regulatory Affairs at SolasCure Ltd, where he leads efforts to gain regulatory approval for Aurase Wound Gel; a new enzymatic debridement agent.  David has 30 years of experience working within regulatory functions of the drug and medical device industries, including regulation of borderline products (e.g.

David Fairlamb

Head of Regulatory Affairs
SolasCure

David Fairlamb

Head of Regulatory Affairs
SolasCure

David Fairlamb is currently Director of Regulatory Affairs at SolasCure Ltd, where he leads efforts to gain regulatory approval for Aurase Wound Gel; a new enzymatic debridement agent.  David has 30 years of experience working within regulatory functions of the drug and medical device industries, including regulation of borderline products (e.g. drug/device combination), prescription medicines, OTC medicines, recombinant biotechnology developments and herbal products across a wide range of therapeutic areas, supporting the development of multiple life science products from product concept through to successful launch.  

During this time, David has held senior regulatory positions within industry at Smith & Nephew plc, Seven Seas Ltd (Merck Consumer Health) and Renovo plc and in 2011 David established ProTherax Ltd as an independent regulatory consultancy working with a range of life sciences start-ups, University academic groups, SMEs as well as established [large] pharma / medical device companies.  David joined SolasCure full time in 2022.

In addition to regulatory positions, David has also held responsibility for medical writing functions, pharmacovigilance (including Qualified Person for Pharmacovigilance) and as the clinical lead in regard to development and validation of clinical endpoints for novel therapeutic indications.

David holds a bachelor’s degree in Pharmacology (University of Portsmouth), a Post-Graduate Certificate in Regulatory Affairs (University of Wales) and is a member of “The Organisation for Professionals in Regulatory Affairs” (TOPRA). David is also a registered Chartered Biologist with the UK Royal Society of Biology.

 

Janette Thomas

Co-founder and Chief Executive Officer
Pellis Care

Janette Thomas

Co-founder and Chief Executive Officer
Pellis Care

Janette Thomas

Co-founder and Chief Executive Officer
Pellis Care
 

Anthony Tickner

Medical Director & Chief Innovation Officer
Saint Vincent Hospital/ Restorixhealth Wound Healing Center

Anthony Tickner

Medical Director & Chief Innovation Officer
Saint Vincent Hospital/ Restorixhealth Wound Healing Center

Anthony Tickner

Medical Director & Chief Innovation Officer
Saint Vincent Hospital/ Restorixhealth Wound Healing Center
 

Conor O'Mahony

Principal Scientist
Tyndall National Institute

Conor O'Mahony

Principal Scientist
Tyndall National Institute

Conor O'Mahony

Principal Scientist
Tyndall National Institute
 

Duncan Purvis

Co-founder and Technical Director
Pellis Care

Duncan Purvis

Co-founder and Technical Director
Pellis Care

Duncan Purvis

Co-founder and Technical Director
Pellis Care

DOWNLOAD THE AGENDA

We're delighted to share the 2022 program for Advanced Wound Care Summit Europe.

Fill out your details to download the agenda here:

DOWNLOAD THE AGENDA

CONFERENCE PACKAGES

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Saturday, November 19, 2022 to Wednesday, December 14, 2022
Tier 1 Academics & Small wound care companies
€1,799
Please note must have max 20 employees and be actively developing a novel wound care therapeutic product
Saturday, November 19, 2022 to Wednesday, December 14, 2022
Tier 2 - Multi-nationals, Large Wound Care Companies, Pharma, Investors
€2,149
Please note multi-nationals and large wound care companies must be actively developing a novel wound care therapeutic product
Saturday, November 19, 2022 to Wednesday, December 14, 2022
Tier 3 - Service/Technology/Solutions Providers and Vendors
€4,299
Including but not limited to material suppliers, CMOs/CROs, and digital health solutions
Preparing registration...

Diamond Partner

SILVER PARTNER

Networking Partner

Exhibitor

Media Partner

PARTNER WITH US

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

To discuss your objectives and partnership opportunities please contact James Tappenden. Sales Director [email protected]

REGISTER YOUR INTEREST

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact Jodie Purser, Marketing Manager, [email protected]

RESOURCES

Download Resource

Venue

Hotel Palace Berlin, Budapester Str.45, 10787 Berlin

We're excited to welcome you face-to-face in Berlin at The Hotel Palace Berlin for the Advanced Wound Care Summit!

If you're still looking for accomodation, please follow this link for the best rates. 

https://hotelmap.com/MG2M6

 

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us